99-12519. Subcommittee of the Biological Response Modifiers Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 64, Number 95 (Tuesday, May 18, 1999)]
    [Notices]
    [Pages 26987-26988]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-12519]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Subcommittee of the Biological Response Modifiers Advisory 
    Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
         This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Subcommittee of the Biological Response 
    Modifiers Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA's regulatory issues.
        Date and Time: The meeting will be held on June 3, 1999, 8:30 a.m. 
    to 6 p.m., and June 4, 1999, 8 a.m. to 3 p.m.
        Location: Holiday Inn, Versailles Ballrooms I and II, 8120 
    Wisconsin Ave., Bethesda, MD.
        Contact Person: Gail M. Dapolito or Rosanna L. Harvey, Center for 
    Biologics Evaluation and Research (HFM-71),
    
    [[Page 26988]]
    
    Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 
    301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-
    8138 (301-443-0572 in the Washington, DC area), code 12389. Please call 
    the Information Line for up-to-date information on this meeting.
        Agenda: On June 3 and 4, 1999, the Xenotransplantation Subcommittee 
    will discuss the following public health issues concerning porcine 
    xenotransplantation: (1) Update of scientific data concerning porcine 
    endogenous retrovirus, (2) update of patient monitoring and screening 
    data concerning patients who have received a porcine xenograft, (3) 
    update on FDA xenotransplantation policy development, and (4) proposals 
    for solid organ xenotransplantation.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by May 27, 1999. 
    Oral presentations from the public will be scheduled between 
    approximately 8:45 a.m. to 9:15 a.m. and 5:30 p.m. to 6 p.m. on June 3, 
    1999. Time allotted for each presentation may be limited. Those 
    desiring to make formal oral presentations should notify the contact 
    person before May 20, 1999, and submit a brief statement of the general 
    nature of the evidence or arguments they wish to present, the names and 
    addresses of proposed participants, and an indication of the 
    approximate time requested to make their presentation.
         Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: May 12, 1999.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 99-12519 Filed 5-13-99; 4:24 pm]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
05/18/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-12519
Pages:
26987-26988 (2 pages)
PDF File:
99-12519.pdf